These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33599003)

  • 1. Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi P; Fearon C; Fasano A; Lang AE
    Mov Disord; 2021 Feb; 36(2):277. PubMed ID: 33599003
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of COVID-19 on Access to Parkinson's Disease Medication.
    Cheong JL; Goh ZHK; Marras C; Tanner CM; Kasten M; Noyce AJ;
    Mov Disord; 2020 Dec; 35(12):2129-2133. PubMed ID: 32860226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 6. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.
    Salari M; Etemadifar M; Zali A; Medghalchi A; Tehrani Fateh S; Aminzade Z; Bagheri Moghaddam S
    Mov Disord; 2021 Apr; 36(4):794-795. PubMed ID: 33733511
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study.
    Kainaga M; Shirota Y; Kodama S; Toda T; Hamada M
    Mov Disord; 2021 Nov; 36(11):2461-2463. PubMed ID: 34432329
    [No Abstract]   [Full Text] [Related]  

  • 10. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 12. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience.
    Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O
    Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid Proof Self-Management Training for Caregivers of Patients with Parkinson's Disease.
    Duits AA; Boots LMM; Mulders AEP; Moonen AJH; Vugt ME
    Mov Disord; 2021 Mar; 36(3):529-530. PubMed ID: 33368615
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.
    Leta V; Rodríguez-Violante M; Abundes A; Rukavina K; Teo JT; Falup-Pecurariu C; Irincu L; Rota S; Bhidayasiri R; Storch A; Odin P; Antonini A; Ray Chaudhuri K
    Mov Disord; 2021 Jun; 36(6):1287-1289. PubMed ID: 33890344
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of probable Parkinson's disease after SARS-CoV-2 infection.
    Cohen ME; Eichel R; Steiner-Birmanns B; Janah A; Ioshpa M; Bar-Shalom R; Paul JJ; Gaber H; Skrahina V; Bornstein NM; Yahalom G
    Lancet Neurol; 2020 Oct; 19(10):804-805. PubMed ID: 32949534
    [No Abstract]   [Full Text] [Related]  

  • 17. In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
    Edwards E; Carroll C
    J Parkinsons Dis; 2020; 10(3):1267-1268. PubMed ID: 32597820
    [No Abstract]   [Full Text] [Related]  

  • 18. Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
    Soares C; Carneiro DR; Dias R; Ferreira D; Sousa M; Oliveira A; Massano J; Morgadinho A; Rosas MJ; Araújo R
    Mov Disord; 2021 Jun; 36(6):1285-1286. PubMed ID: 33834516
    [No Abstract]   [Full Text] [Related]  

  • 19. May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
    Spina Tensini F; Spina Tensini T; Franklin GL; Teive HAG
    Parkinsonism Relat Disord; 2020 Aug; 77():20. PubMed ID: 32575004
    [No Abstract]   [Full Text] [Related]  

  • 20. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.